Aviva »

Keros Therapeutics shares owned by Aviva

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Aviva from 13F filings

Historical chart of Aviva investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Aviva consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Aviva

Quarter filed Position value Share count Share price at filing
2026-03-31 $379k 34k 11.04

More positions owned by Aviva

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Aviva

Top funds holding Keros Therapeutics

BlackRock
Vanguard Group
Nantahala Capital Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Vanguard Capital Management
Madison Avenue Partners
Qube Research & Technologies
OrbiMed Advisors
Jacobs Levy Equity Management
Federated Investors
Vanguard Portfolio Management
Geode Capital Management
Renaissance Technologies
Citadel Advisors

View all funds holding Keros Therapeutics